Medtronic (MDT) Competitors $82.94 -0.64 (-0.77%) (As of 12/11/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends MDT vs. ABT, ISRG, SYK, BSX, BDX, EW, RMD, IDXX, DXCM, and STEShould you be buying Medtronic stock or one of its competitors? The main competitors of Medtronic include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Boston Scientific (BSX), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), ResMed (RMD), IDEXX Laboratories (IDXX), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry. Medtronic vs. Abbott Laboratories Intuitive Surgical Stryker Boston Scientific Becton, Dickinson and Company Edwards Lifesciences ResMed IDEXX Laboratories DexCom STERIS Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, community ranking, institutional ownership and media sentiment. Is ABT or MDT a better dividend stock? Abbott Laboratories pays an annual dividend of $2.20 per share and has a dividend yield of 1.9%. Medtronic pays an annual dividend of $2.80 per share and has a dividend yield of 3.4%. Abbott Laboratories pays out 66.9% of its earnings in the form of a dividend. Medtronic pays out 85.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Abbott Laboratories has increased its dividend for 53 consecutive years and Medtronic has increased its dividend for 48 consecutive years. Is ABT or MDT more profitable? Abbott Laboratories has a net margin of 13.99% compared to Medtronic's net margin of 13.00%. Abbott Laboratories' return on equity of 20.18% beat Medtronic's return on equity.Company Net Margins Return on Equity Return on Assets Abbott Laboratories13.99% 20.18% 10.84% Medtronic 13.00%13.79%7.62% Do analysts recommend ABT or MDT? Abbott Laboratories presently has a consensus target price of $130.07, suggesting a potential upside of 13.94%. Medtronic has a consensus target price of $95.27, suggesting a potential upside of 14.86%. Given Medtronic's higher probable upside, analysts clearly believe Medtronic is more favorable than Abbott Laboratories.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abbott Laboratories 0 Sell rating(s) 4 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.75Medtronic 1 Sell rating(s) 9 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.41 Do institutionals & insiders believe in ABT or MDT? 75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by company insiders. Comparatively, 0.2% of Medtronic shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has preferable valuation & earnings, ABT or MDT? Abbott Laboratories has higher revenue and earnings than Medtronic. Medtronic is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbbott Laboratories$41.22B4.80$5.72B$3.2934.70Medtronic$33.00B3.22$3.68B$3.2725.36 Does the MarketBeat Community favor ABT or MDT? Medtronic received 653 more outperform votes than Abbott Laboratories when rated by MarketBeat users. Likewise, 75.64% of users gave Medtronic an outperform vote while only 69.70% of users gave Abbott Laboratories an outperform vote. CompanyUnderperformOutperformAbbott LaboratoriesOutperform Votes93469.70% Underperform Votes40630.30% MedtronicOutperform Votes158775.64% Underperform Votes51124.36% Which has more risk & volatility, ABT or MDT? Abbott Laboratories has a beta of 0.73, meaning that its share price is 27% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500. Does the media refer more to ABT or MDT? In the previous week, Medtronic had 13 more articles in the media than Abbott Laboratories. MarketBeat recorded 42 mentions for Medtronic and 29 mentions for Abbott Laboratories. Medtronic's average media sentiment score of 1.14 beat Abbott Laboratories' score of 1.13 indicating that Medtronic is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 23 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Medtronic 27 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryAbbott Laboratories beats Medtronic on 13 of the 22 factors compared between the two stocks. Ad Timothy SykesPrepare Now Before This Looming $2 Trillion D.C. ShockMillions of traders could get blindsided by this election-year shock on December 18th… And if you do nothing now, you could wind up panicking in the next 30 days… or worse, making a costly mistake.Click here to watch his emergency briefing >>> Get Medtronic News Delivered to You Automatically Sign up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDT vs. The Competition Export to ExcelMetricMedtronicElectromedical equipment IndustryMedical SectorNYSE ExchangeMarket Cap$106.35B$3.12B$5.31B$20.11BDividend Yield3.33%1.71%5.17%3.47%P/E Ratio25.3618.54137.3044.05Price / Sales3.2274.331,231.0119.44Price / Cash11.6641.4036.4218.54Price / Book2.183.914.785.53Net Income$3.68B$92.21M$119.64M$987.20M7 Day Performance-1.43%0.77%1.49%-0.20%1 Month Performance-6.02%-1.57%-0.61%1.40%1 Year Performance3.55%15.29%33.23%23.05% Medtronic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDTMedtronic4.9769 of 5 stars$82.94-0.8%$95.27+14.9%+4.0%$106.35B$33.00B25.3695,000Dividend AnnouncementShort Interest ↓Positive NewsABTAbbott Laboratories4.9685 of 5 stars$114.60-0.9%$130.07+13.5%+7.5%$198.77B$40.11B35.14114,000Short Interest ↑Positive NewsISRGIntuitive Surgical4.7949 of 5 stars$550.41+0.5%$541.33-1.6%+72.3%$196.05B$7.12B88.4913,676Analyst ForecastInsider TradeShort Interest ↓Positive NewsSYKStryker4.9502 of 5 stars$379.84-1.3%$398.40+4.9%+28.3%$144.80B$20.50B41.2752,000Dividend IncreaseAnalyst ForecastPositive NewsBSXBoston Scientific4.5058 of 5 stars$88.70-1.5%$93.52+5.4%+63.8%$130.73B$14.24B73.9248,000Analyst ForecastShort Interest ↑Positive NewsBDXBecton, Dickinson and Company4.9944 of 5 stars$222.81+1.7%$283.50+27.2%-5.3%$64.42B$20.18B37.0474,000Ex-DividendInsider TradeShort Interest ↓Positive NewsEWEdwards Lifesciences4.0097 of 5 stars$71.00-0.7%$78.35+10.4%+4.9%$41.88B$6.00B10.3219,800Analyst ForecastShort Interest ↑Analyst RevisionRMDResMed4.657 of 5 stars$244.82+1.4%$225.70-7.8%+50.3%$35.94B$4.69B31.979,980Analyst RevisionIDXXIDEXX Laboratories4.9496 of 5 stars$435.69+1.9%$539.63+23.9%-18.5%$35.68B$3.66B42.0111,000Short Interest ↓Positive NewsDXCMDexCom4.9474 of 5 stars$77.91+0.2%$101.88+30.8%-31.7%$30.43B$3.62B46.479,600Analyst ForecastShort Interest ↓STESTERIS4.9804 of 5 stars$216.31+0.2%$262.50+21.4%+3.9%$21.35B$5.14B49.2918,179Short Interest ↑Positive News Related Companies and Tools Related Companies ABT Competitors ISRG Competitors SYK Competitors BSX Competitors BDX Competitors EW Competitors RMD Competitors IDXX Competitors DXCM Competitors STE Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:MDT) was last updated on 12/12/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredEx-Lawyer turns $50k into $5 million tradingHe was a lawyer by day, secret trader by night...or in this case by lunch… With nothing but a laptop and a ...Investing Daily | SponsoredWant to Start Investing? It’s Easier Than You Think!Many people think you need a lot of money to start investing—but that’s simply not true. Andy Tanner, Rich ...The Cashflow Academy | SponsoredPrepare Now Before This Looming $2 Trillion D.C. ShockMillions of traders could get blindsided by this election-year shock on December 18th… And if you do nothin...Timothy Sykes | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medtronic plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Medtronic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDT Stock Alerts